Sitting behavior in office workers. -
Conditions
Interventions
Intervention 1: Intervention group 2: 15 office personnel will work in accordance with the schedule of 45 minutes in sitting and 15 minutes in standing position for 2 months (working hours of 7 to 8 p
Prevention
Intervention group 2: 15 office personnel will work in accordance with the schedule of 45 minutes in sitting and 15 minutes in standing position for 2 months (working hours of 7 to 8 per day). In this
Intervention group 1: 15 office personnel will work in accordance with the schedule of 30 minutes in sitting and 30 minutes in standing position for 2 months (working hours of 7 to 8 per day). In this
Control group: 15 office personnel will work like before (in sitting position) for 2 months (working hours of 7 to 8 per day).
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: People's willingness to participate in the study; Job experience more than 1 year. Exclusion criteria: Presence of acute musculoskeletal disorders in the spine and lower limbs; Presence of mental and hormonal disorders; People who follow a specific dietary regime; People who follow a specific exercise schedule.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue. Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Multidimensional Assessment of Fatigue (MAF) scale.;Productivity. Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Health and Work Questionnaire (HWQ).;Energy expenditure. Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Bodymedia sensewear system.;High-Density Lipoprotein (HDL). Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Autoanalyzer apparatus.;Low-Density Lipoprotein (LDL). Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Autoanalyzer apparatus.;Blood glucose. Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Autoanalyzer apparatus.;Blood cortisol. Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Enzyme-Linked Immunosorbent Assay (ELISA) method.;Blood insulin. Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Enzyme-Linked Immunosorbent Assay (ELISA) method.;Proinflammatory factor of high-sensitivity C-Reactive Protein (hs-CRP). Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Enzyme-Linked Immunosorbent Assay (ELISA) method.;Interleukin 6 (IL-6). Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Enzyme-Linked Immunosorbent Assay (ELISA) method.;Tumor Necrosis Factor-a (TNF-a). Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Enzyme-Linked Immunosorbent Assay (ELISA) method.;Blood serotonin. Timepoint: Before intervention, 2 months after the beginning of the intervention. Method of measurement: Enzy | — |
Secondary
| Measure | Time frame |
|---|---|
| -. Timepoint: -. Method of measurement: -. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHadi Daneshmandi
Shiraz University of Medical Sciences
Outcome results
None listed